These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9719943)

  • 21. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor.
    Wang WC; Cordoba J; Infante AJ; Conley ME
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):160-3. PubMed ID: 7513136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
    Shi Y; Han X; He X; Yang J; Liu P
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):462-6. PubMed ID: 12133516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
    Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
    Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
    Ozcan M; Ustün C; Akçağlayan E; Akan H; Arslan O; Ilhan O; Beksaç M; Gürman G; Demirer T; Arat M; Celebi H; Konuk N; Uysal A; Koç H
    Bone Marrow Transplant; 2001 Mar; 27(5):499-505. PubMed ID: 11313683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Umbilical cord blood stem cell transplantation from unrelated HLA-matched donor in an infant with severe congenital neutropenia.
    Mino E; Kobayashi R; Yoshida M; Suzuki Y; Yamada M; Kobayashi K
    Bone Marrow Transplant; 2004 May; 33(9):969-71. PubMed ID: 15004540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia.
    Hirashima K; Yoshida Y; Asano S; Takaku F; Omine M; Furusawa S; Abe T; Abe T; Dohy H; Tajiri M
    Biotherapy; 1991; 3(4):297-307. PubMed ID: 1723891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [rhG-CSF treatment in cyclic neutropenia. Continuous versus intermittent rhG-CSF treatment in cyclic neutropenia].
    Nielsen H; Hansen PB
    Ugeskr Laeger; 1994 Jan; 156(3):324-5. PubMed ID: 8296427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].
    Qiu HY; Wu DP; Sun AN; Chang WR; Jin ZM; Miao M; Tang XW; Shen YM; Fu ZZ
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):462-5. PubMed ID: 15555260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
    Shochat E; Rom-Kedar V
    Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of idiopathic neutropenia in the elderly with recombinant human granulocyte colony-stimulating factor.
    Sonoda Y; Yashige H; Fujii H; Maekawa T; Abe T
    Acta Haematol; 1991; 85(3):146-52. PubMed ID: 1710409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
    Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
    Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
    Kuritzkes DR
    Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.